Bell, K.M., Potkin, S.G., Carreon, D., Plon, L.: "S-adenosylmethionine blood levels in major depression: changes with drug treatment." Acta Neurol Scand 1994, Ausgabe 154: 15-18

Bressa, G.M.: "S-adenosylmethionine as antidepressant: meta-analysis of clinical studies." Acta Neurol Scand 1994, Ausgabe 154, 7-14

Bottiglieri, T., Hyland, K., Reynolds, E.H.: "The clinical potential of Ademethionie (S-adenosylmethonine) in neurological disorders". Drugs. 1994;48(2):137-152.

Carney, M.W.P., Toone, B.K., Reynolds, E.H.: "S-adenosylmethionine and affective disorder". Am J Med. 1987;83(suppl 5A):104-106.

Caruso, I., Pietrogrande, V.: "Italian double-blind multicenter study comparing S-adenosylmethionine, naproxen and placebo in the treatment of degenerative joint disease". Am J Med. 1987;83(suppl 5A):66-71.

Chawla, R.K., Bonkovsky, H.L., Galambos, J.T.: "Biochemistry and pharmacology of S-adenosylmethionine and rationale for its use in liver disease." 1990, Drugs, 40. Ausgabe, 3:98-110

Chawla, R.K., Jones, D.P.: "Abnormal metabolism of S-adenosylmethionine in hypoxic rat liver. Similarities to its abnormal metabolism in alcoholic cirrhosis." Biochem Biophys Acta, 5. Januar 1994

Clouatre, D.: "All about SAMe". Avery Publishing Group, New York, 1999

Di Padova, C.: "S-adenosylmethionine in the treatment of osteoarthritis". Review of Clinical Studies, Am. J. Med. 1987, 83, Supplement 5A, pp. 60-5.

Di Rocco, A., Rogers, J.D., Brown, R., Werner, P., Bottiglieri, T.: "S-adenosyl-methionine improves depression in patients with Parkinsons's disease in an open-label clinical trial." Mov. Discord, Nov. 2000, 15(6):1225-9

Frezza M, Surrenti C, Manzillo G et al. Oral S-adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis, A double-blind, placebo controlled study. Gastroenterology. 1990;99:211-215.

Gatto, G., Caleri, D., Michelacci, S, Sicuteri, F.: "Analgesizing effect of a methyl donor (S-adenosylmethionine) in migraine: an open clinical trial." Int J. Clin Pharm Res 6(1):15-17

Ischoulon, D., Fava, M.: "SAMe, eine Aminosäure, kann vor Depressionen schützen und eignet sich auch zu deren Behandlung, in dem es die Synthese der Neurotransmitter im Gehirn verbessert". Am J Clin Nutr 2002; 76 (suppl): 1158s-1161s).

Kagan, B.L., Sultzer, D.L., Rosenlicht, N.: "Oral S-adenosylmethionine in depression: a randomized, double-blind, placebo-controlled trial". Am J Psychiatry. 1990;147(5):591-595.

König, B.: "A long-term (two years) clinical trial with S-adenosylmethionine for the treatment of osteoarthritis". Am J Med. 1987;83(Suppl 5A):89-94.

Löhrer, F.M., Angst, C.P., Häfeli, W.E., Jordan, P.P., Ritz, R., Fowler, B.: "Low whole-blood S-adenosylmethionine and correlation between 5-methyltetrahydrofolate and homocysteine in coronary heart disease." Arterioscler Thromb Vasc Biol, Juni 1996, 16(6):727-33

Löhrer, F.M., Schwab, R., Angst, C.P. Häfeli, W.E., Fowler, B.: "Influence of oral S-adenosylmethionine on plasma 5-methyltetrahydrofolate, S-adenosylhomocysteine, homocysteine and methionine in healthy humans." J Pharmacol Exp Ther, August 1997, 282(2):845-50

Marcologno, R., Colombo, B. et al: "Double-blind multi center study of the activity of S-adenosyl-methionin in hip osteoarthritis". Current Therapeutic Research, 1985, 37 pp. 82-94.

Massing, A., Di Giorgio, E.E., Capstan, O., et al.: "Double-blind controlled clinical trial of oral S-adenosylmethionine versus piroxicam in knee osteoarthritis". Am J Med. 1987; 83(Sup 5A): 72-77.

Miller, J.W., Nadeau, M.R., Smith, J., Smith, D., Selhub, J.: "Folate-deficiency-induced homocysteinaemia in rats: disruption of S-adenosylmethionine's coordinate regulation of homocysteine metabolism." Biochem J., März 1994, 298: 415-9

Müller-Fassbender, H.: "Double blind clinical trial of S-adenosymethionine versus Ibuprofen in the treatment of osteoarthritis". Am J Med, 20. Nov. 1987, 83(5A), 81-83

Newman, N.M., Ling, R.S.M.: "Acetabular bond destruction related to non-steroidal anti-inflammatory drugs". Lancet, 1985 iim pp. 11-13.

Pezzoli, C., Galli-Kienle, M., Stramentinoli, G.: "Lack of mutagenic activity of ademethionine in vitro and in vivo". Arzneimittelforschung, Juli 1987, 37(7):826-9

Salmaggi, P., Bressa, G.M., Nicchia, G., Coniglio, M., La Greca, P., Le Grazie, C.: "Double-blind, placebo-controlled study of S-adenosylmethionine in depressed postmenopausal women." Psychother Psychosom 1993, 59(1):34-40

Sherer, M.A., Cantoni, G.L., Golden, R.N., Rudorfer, M.V., Potter, W.Z.: "Effects of S-adenosylmethionine on plasma norepinephrine, blood pressure and heart rate in healthy volunteers." Psychiatry Res, Februar 1986, 17(2):111-8

Stramentinoli, G., Gaulano, M., Galli-Kienle, M.: "Intestinal absorption of S-adenosylmethionine". J. Pharmacol Exp Ther, Juni 1979, 209(3):323-6

Tavoni, A., Vitale, C., Bombardieri, S., et al.: "Evaluation of S-adenosylmethionine in primary fibromyalgia, a double-blind crossover study". Am J Med. 1987;83(suppl 5A):107-110.

Turchetti, V., Bellini, M.A., Leoncini, F., Petri, F. Trabalzini, L., Guerrini, M., Forconi, S.: "Blood viscosity and red cell morphology in subjects suffering from cirrhosis before and after treatment with S-adenosylmethionine." Clin Hemorheol Microcirc 2000, 22(3):215-21

Volkmann, H., Norregaard, J., Jacobsen, S., Danneskiold-Samsoe, B., Knoke, G., Nehrdich, D.: "Double-blind, placebo controlled cross-over study of intravenous S-adenosyl-L-methionine in patients with fibromyalgia." Scand J Rheumatol, 26(3): 206-11

Watson, W.H., Zhao, Y., Chawla, R.K.: "S-adenosylmethionine attenuates the lipopolysaccharide-induced expression of the gene for tumour necrosis factor alpha". Biochem J., 15. August 1999, 342:21-5